Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.59, read 2026-11-03
Ethical does not pass the values gate
Price286.47 USD
Fair value408.41
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-26Read Distribution351.49-18.5% to today ✓Markdown gives way to Distribution
2026-10-22Read Markdown351.49-18.5% to today ✓Accumulation gives way to Markdown
2026-10-02Read Accumulation362.08-20.9% to today Distribution gives way to Accumulation after a 7% rise in 2 weeks
2026-09-16Read Distribution338.37-15.3% to today ✓Markup gives way to Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Wesco International Inc holds its Distribution at $286.47. The statistical read favours the sellers, held for 95 days.
As held on the ledger · 2026-11-05
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 95 days
Price at the screen
$286.47
Valuation
22.79 trailing · 16.40 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.55
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
39.61%
Below 33%
Interest-bearing debt is 39.6% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
28.34%
Below 49%
Money owed to the company is 28.3% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Wesco International's business is in a permissible area, but its interest-bearing debt is about 40% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when WCC's ethical verdict changes
Today WCC does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 22% discount to our $408.41 fair value, narrow competitive moat, 13.00% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 29.9% discount to the base estimate.
Where our models see it going: fair-value estimate $408.41, with a range of $301.36 to $502.26, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Behind Every Build Site Lies a Middleman
Picture the cables, switchgear and safety kit that keep a new data hall or factory floor running. Wesco moves those goods from factory gate to job site across three continents. Revenue is rising 14 percent, the shares sit 18 percent below our fair value and the ethical screen raises no flags, yet the opportunity rating stays at none.
The business earns a narrow moat and just 3 percent net margins on 13 percent return on equity. At 17.4 times forward earnings the valuation looks reasonable beside analyst targets near 400 dollars, but a distributor with limited pricing power rarely compounds at a premium to the cycle.
Industrial demand can swing sharply with construction and manufacturing spending. A low multiple on peak earnings has trapped investors before. We therefore stand aside. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
WCC trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Distribution$316.72-3.9%Entry 16
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (11 analysts) rates it buy, with a mean price target of $381.
2026-10-29Distribution$329.50+0.0%Entry 15
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (11 analysts) rates it buy, with a mean price target of $381. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Distribution$329.50+0.0%Entry 14
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (11 analysts) rates it buy, with a mean price target of $381. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Distribution$329.50-6.3%Entry 13
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (11 analysts) rates it buy, with a mean price target of $381. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (11 analysts) rates it buy, with a mean price target of $381. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markdown$351.49+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (11 analysts) rates it buy, with a mean price target of $381. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Markdown$351.49+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (11 analysts) rates it buy, with a mean price target of $381. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markdown$351.49+0.0%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (11 analysts) rates it buy, with a mean price target of $381. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markdown · changed$351.49+0.0%Entry 8
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (11 analysts) rates it buy, with a mean price target of $381. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Accumulation$351.49-2.9%Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 35% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (11 analysts) rates it buy, with a mean price target of $381.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
